This study elucidated the critical role of oxidative stress and inflammatory factors, as well as BACE1, as a novel factor previously measured in AD diagnosis and treatment through the assessment of their blood levels in patients with SS and their potential role in the progression of neurocognitive symptoms in Sjogren’s syndrome patients. This evidence concerns the gene BACE1 and synovial sarcoma.